Federated Hermes’s Loxo Oncology, Inc LOXO Stock Holding History

Federated Hermes’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-82,591	Closed	-$11.6M	–	2287
2018 Q4	$11.6M	Buy	82,591 +17,433	+27%	+$2.65M	0.03%	444
2018 Q3	$11.1M	Buy	65,158 +1,935	+3%	+$325K	0.03%	535
2018 Q2	$11M	Buy	63,223 +32,192	+104%	+$4.84M	0.03%	421
2018 Q1	$3.58M	Buy	+31,031	New	+$3.3M	0.01%	743
2017 Q4	–	Sell	-34,377	Closed	-$3.17M	–	2269
2017 Q3	$3.17M	Sell	34,377 -2,881	-8%	-$224K	0.01%	733
2017 Q2	$2.99M	Buy	37,258 +37,086	+21,562%	+$2.05M	0.01%	740
2017 Q1	$7K	Buy	+172	New	+$7.08K	﹤0.01%	1891

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Federated Hermes's LOXO Position: Q1 2019 in Review

Federated Hermes sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 82,591 shares — an estimated $11.6M sold.

Federated Hermes first reported a position in LOXO in Q1 2017 and held it in 7 quarters. The position peaked at $11.6M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Federated Hermes reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Federated Hermes sold 82,591 Loxo Oncology, Inc shares in Q1 2019, an estimated $11.6M.
Federated Hermes first reported a position in Loxo Oncology, Inc in Q1 2017 and held it in 7 quarters.
Federated Hermes's Loxo Oncology, Inc position peaked at $11.6M in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Federated Hermes's 13F filing for Q1 2019, filed 10 May 2019.